Howe & Rusling’s Ocugen OCGN Stock Holding History

Howe & Rusling’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,000	Closed	-$9K	–	801
2022 Q3	$9K	Hold	5,000	–	–	﹤0.01%	559
2022 Q2	$11K	Buy	+5,000	New	+$12K	﹤0.01%	522

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Howe & Rusling's OCGN Position: Q4 2022 in Review

Howe & Rusling sold out of Ocugen (OCGN) in Q4 2022, closing a stake of 5,000 shares — an estimated $9K sold.

Howe & Rusling first reported a position in OCGN in Q2 2022 and held it in 2 quarters. The position peaked at $11K in Q2 2022. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2022.

Howe & Rusling reported no remaining Ocugen position as of Q4 2022 after selling out during the quarter.
Howe & Rusling sold 5,000 Ocugen shares in Q4 2022, an estimated $9K.
Howe & Rusling first reported a position in Ocugen in Q2 2022 and held it in 2 quarters.
Howe & Rusling's Ocugen position peaked at $11K in Q2 2022.
114 funds tracked by Wall St. Rank held Ocugen as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.